Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six weeks.

Saved in:
Bibliographic Details
Main Authors: Allan Gordon, Saifudin Rashiq, Dwight E Moulin, Alexander J Clark, André D Beaulieu, John Eisenhoffer, Paula S Piraino, Patricia Quigley, Zoltan Harsanyi, Andrew C Darke
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2010/216725
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six weeks.
ISSN:1203-6765

Similar Items